Patients with high risk adenocarcinoma of the prostate
Showing 1 - 25 of >10,000
Adenocarcinoma of the Prostate Trial in Montreal (Androgen suppression plus radiation therapy)
Active, not recruiting
- Adenocarcinoma of the Prostate
- Androgen suppression plus radiation therapy
-
Montreal, Quebec, Canada
- +1 more
Jan 30, 2023
Prostate Adenocarcinoma Trial in Dallas (68-Ga PSMA11)
Not yet recruiting
- Prostate Adenocarcinoma
- 68-Ga PSMA11
-
Dallas, TexasUT Southwestern Medical Center
Sep 12, 2023
Prostate Cancer, Prostate Adenocarcinoma Trial (drug, other, procedure)
Not yet recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
- Relacorilant
- +4 more
- (no location specified)
Feb 2, 2023
Prostate Adenocarcinoma, Stage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8, Stage IIC Prostate Cancer AJCC
Recruiting
- Prostate Adenocarcinoma
- +7 more
- High-Dose Rate Brachytherapy
- Stereotactic Body Radiation Therapy
-
Los Angeles, CaliforniaUniversity of California at Los Angeles / Jonsson Comprehensive
Oct 13, 2022
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage III Prostate Cancer AJCC v8 Trial in Scottsdale, Rochester
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Androgen Suppression
- +3 more
-
Scottsdale, Arizona
- +1 more
Jan 5, 2023
Prostate Cancer, BRCA1 Mutation, BRCA2 Mutation Trial (Olaparib, LHRH agonist)
Not yet recruiting
- Prostate Cancer
- +4 more
- Olaparib
- LHRH agonist
- (no location specified)
Aug 10, 2022
Prostate Cancer, Prostate Adenocarcinoma Trial in Netherlands
Recruiting
- Prostate Cancer
- Prostate Adenocarcinoma
-
Alkmaar, Netherlands
- +27 more
Jun 27, 2023
Prostate Cancer, Prostate Cancer Adenocarcinoma, Non-Metastatic Trial in Durham (Cabozantinib, Radical Prostatectomy)
Terminated
- Prostate Cancer
- +2 more
- Cabozantinib
- Radical Prostatectomy
-
Durham, North CarolinaDuke University Medical Center
Jun 3, 2022
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Prostate Adenocarcinoma, Prostate Cancer, High Risk Prostate Cancer Trial in Baltimore, Boston, Seattle (Enzalutamide,
Completed
- Prostate Adenocarcinoma
- +2 more
- Enzalutamide
- +3 more
-
Baltimore, Maryland
- +3 more
Mar 30, 2022
Adenocarcinoma of the Prostate, Stage III Prostate Cancer Trial in Los Angeles (radiation, other, drug)
Active, not recruiting
- Adenocarcinoma of the Prostate
- Stage III Prostate Cancer
- stereotactic body radiation therapy
- +3 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center
Apr 28, 2022
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial in Philadelphia
Recruiting
- Prostate Adenocarcinoma
- +2 more
- MRI-guided Intensity-Modulated Radiation Therapy
- +7 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jan 4, 2023
Stage II Prostate Adenocarcinoma, Stage III Prostate Adenocarcinoma Trial in Palo Alto (68Ga-PSMA-11, Magnetic resonance imaging
Completed
- Stage II Prostate Adenocarcinoma
- Stage III Prostate Adenocarcinoma
- 68Ga-PSMA-11
- +2 more
-
Palo Alto, CaliforniaStanford University, School of Medicine
Mar 2, 2022
Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7, Stage II Prostate Adenocarcinoma AJCC v7, Stage
Active, not recruiting
- Stage I Prostate Adenocarcinoma American Joint Committee on Cancer (AJCC) v7
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Los Angeles, CaliforniaUCLA / Jonsson Comprehensive Cancer Center
Dec 7, 2021
Prostate Cancer, Prostatic Adenocarcinoma Trial in New York (degarelix injection, androgen deprivation therapy)
Active, not recruiting
- Prostate Cancer
- Prostatic Adenocarcinoma
- degarelix injection
- androgen deprivation therapy
-
New York, New YorkMemorial Sloan Kettering Cancer Center
Feb 28, 2022
Adenocarcinoma of Prostate, Progression of Prostate Cancer Trial in Villejuif (Cabazitaxel, Pelvic radiotherapy, prostate
Active, not recruiting
- Adenocarcinoma of Prostate
- Progression of Prostate Cancer
- Cabazitaxel
- +2 more
-
Villejuif, FranceInstitut Gustave Roussy
Oct 5, 2021
Adenocarcinoma of the Prostate Trial in Sacramento (Stereotactic Radiosurgical Boost, Casodex, Leuprolide)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiosurgical Boost
- +2 more
-
Sacramento, CaliforniaUC Davis Sacramento Cancer Center Dept of Radiation Oncology
Sep 24, 2021
Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8 Trial in Houston (biological,
Active, not recruiting
- Prostate Adenocarcinoma
- +5 more
- Daratumumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 25, 2022
Prostate Adenocarcinoma Trial in Salt Lake City (MVA-BN-Brachyury)
Withdrawn
- Prostate Adenocarcinoma
- MVA-BN-Brachyury
-
Salt Lake City, UtahHuntsman Cancer Institute
Sep 21, 2021
Prostate Cancer Trial in Jacksonville (< 15% risk of + LN, > 15% risk of + LN)
Active, not recruiting
- Prostate Cancer
- < 15% risk of + LN
- > 15% risk of + LN
-
Jacksonville, FloridaUniversity of Florida Proton Therapy Institute
Dec 1, 2021
Adenocarcinoma of the Prostate Trial in Jacksonville (HR-A, HR-B)
Recruiting
- Adenocarcinoma of the Prostate
- HR-A
- HR-B
-
Jacksonville, FloridaUniversity of Florida Health Proton Therapy Institute
Mar 14, 2022
Prostate Adenocarcinoma Trial in Park Ridge (CyberKnife, Androgen Deprivation Therapy (ADT), Intensity Modulated radiation
Recruiting
- Prostate Adenocarcinoma
- CyberKnife
- +2 more
-
Park Ridge, IllinoisAdvocate Lutheran General Hospital
Jul 19, 2021
Prostate Adenocarcinoma, Radiation Toxicity Trial in Limassol (External beam radiation therapy, High-dose-rate brachytherapy,
Recruiting
- Prostate Adenocarcinoma
- Radiation Toxicity
- External beam radiation therapy, High-dose-rate brachytherapy
- Goserelin 10.8 mg
-
Limassol, CyprusGerman Oncology Center
Aug 6, 2021
Adenocarcinoma of the Prostate Trial in Dijon (Stereotactic Radiotherapy with Linac MRI)
Recruiting
- Adenocarcinoma of the Prostate
- Stereotactic Radiotherapy with Linac MRI
-
Dijon, FranceCentre Georges François Leclerc
May 27, 2021
Prostate Adenocarcinoma, Stage IIB Prostate Cancer AJCC v8, Stage IIC Prostate Cancer AJCC v8 Trial in Houston (drug,
Completed
- Prostate Adenocarcinoma
- +4 more
- Abiraterone Acetate
- +4 more
-
Houston, TexasM D Anderson Cancer Center
Jul 14, 2022